Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Um direcionamento-GPC3 anticorpo Bispecific,…
JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content.

JoVE Journal Cancer Research
Um direcionamento-GPC3 anticorpo Bispecific, GPC3-S-Fab, com potente citotoxicidade
Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
Journal (Cancer Research)
Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Journal (Cancer Research)
Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
 
Click here for the English version

Um direcionamento-GPC3 anticorpo Bispecific, GPC3-S-Fab, com potente citotoxicidade

Article DOI: 10.3791/57588-v • 11:13 min • July 12th, 2018
July 12th, 2018 •
1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2
1School of Pharmaceutical Sciences, Sun Yat-Sen University, 2Center for Cellular & Structural Biology, Sun Yat-Sen University

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Aqui, apresentamos um protocolo para produzir um anticorpo bispecific GPC3-S-Fab em Escherichia coli. O GPC3-S-Fab purificado tem potente citotoxicidade contra células de câncer de fígado positivo GPC3.

Tags

Pesquisa sobre o câncer edição 137 Bispecific anticorpo o anticorpo único domínio VHH GPC3-S-Fab GPC3 câncer de fígado
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter